Go Pro

Westlake Chemical Partners (WLKP) Competitors

Westlake Chemical Partners logo
$22.00 -0.15 (-0.66%)
Closing price 07/10/2026 03:59 PM Eastern
Extended Trading
$21.96 -0.04 (-0.18%)
As of 07/10/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WLKP vs. CC, NGVT, PCT, ECVT, and UAN

Should you buy Westlake Chemical Partners stock or one of its competitors? MarketBeat compares Westlake Chemical Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Westlake Chemical Partners include Chemours (CC), Ingevity (NGVT), PureCycle Technologies (PCT), Ecovyst (ECVT), and CVR Partners (UAN). These companies are all part of the "chemicals" industry.

How does Westlake Chemical Partners compare to Chemours?

Westlake Chemical Partners (NYSE:WLKP) and Chemours (NYSE:CC) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Westlake Chemical Partners pays an annual dividend of $1.89 per share and has a dividend yield of 8.6%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.0%. Westlake Chemical Partners pays out 115.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -13.3% of its earnings in the form of a dividend.

Chemours has a consensus target price of $24.10, suggesting a potential upside of 35.33%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Westlake Chemical Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Westlake Chemical Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Chemours
1 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.42

Westlake Chemical Partners has a net margin of 4.69% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Westlake Chemical Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Westlake Chemical Partners4.69% 7.15% 4.57%
Chemours -6.82%52.49%1.78%

Westlake Chemical Partners has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

In the previous week, Chemours had 2 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 3 mentions for Chemours and 1 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 1.11 beat Chemours' score of 0.89 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Westlake Chemical Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemours
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Westlake Chemical Partners has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westlake Chemical Partners$1.17B0.66$48.70M$1.6413.42
Chemours$5.81B0.46-$386M-$2.64N/A

Summary

Westlake Chemical Partners beats Chemours on 11 of the 18 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Ingevity?

Westlake Chemical Partners (NYSE:WLKP) and Ingevity (NYSE:NGVT) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

Westlake Chemical Partners has a net margin of 4.69% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Westlake Chemical Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Westlake Chemical Partners4.69% 7.15% 4.57%
Ingevity -10.55%207.82%9.70%

78.3% of Westlake Chemical Partners shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 1.1% of Westlake Chemical Partners shares are held by company insiders. Comparatively, 0.9% of Ingevity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Westlake Chemical Partners had 1 more articles in the media than Ingevity. MarketBeat recorded 1 mentions for Westlake Chemical Partners and 0 mentions for Ingevity. Westlake Chemical Partners' average media sentiment score of 1.11 beat Ingevity's score of 1.00 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company Overall Sentiment
Westlake Chemical Partners Positive
Ingevity Positive

Westlake Chemical Partners has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

Ingevity has a consensus target price of $80.00, indicating a potential upside of 10.69%. Given Ingevity's higher possible upside, analysts clearly believe Ingevity is more favorable than Westlake Chemical Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Westlake Chemical Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Ingevity
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Westlake Chemical Partners has higher earnings, but lower revenue than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westlake Chemical Partners$1.17B0.66$48.70M$1.6413.42
Ingevity$1.18B2.13-$167.10M-$3.55N/A

Summary

Westlake Chemical Partners and Ingevity tied by winning 8 of the 16 factors compared between the two stocks.

How does Westlake Chemical Partners compare to PureCycle Technologies?

Westlake Chemical Partners (NYSE:WLKP) and PureCycle Technologies (NASDAQ:PCT) are both small-cap chemicals companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 63.0% of PureCycle Technologies shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by company insiders. Comparatively, 18.8% of PureCycle Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

PureCycle Technologies has a consensus target price of $12.25, indicating a potential upside of 67.81%. Given PureCycle Technologies' higher possible upside, analysts plainly believe PureCycle Technologies is more favorable than Westlake Chemical Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Westlake Chemical Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
PureCycle Technologies
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Westlake Chemical Partners has a net margin of 4.69% compared to PureCycle Technologies' net margin of -2,062.36%. Westlake Chemical Partners' return on equity of 7.15% beat PureCycle Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Westlake Chemical Partners4.69% 7.15% 4.57%
PureCycle Technologies -2,062.36%-393.01%-22.56%

In the previous week, PureCycle Technologies had 1 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 2 mentions for PureCycle Technologies and 1 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 1.11 beat PureCycle Technologies' score of 0.94 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Westlake Chemical Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PureCycle Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Westlake Chemical Partners has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westlake Chemical Partners$1.17B0.66$48.70M$1.6413.42
PureCycle Technologies$8.35M158.12-$182.57M-$1.47N/A

Westlake Chemical Partners has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market. Comparatively, PureCycle Technologies has a beta of 2.5, suggesting that its stock price is 150% more volatile than the broader market.

Summary

Westlake Chemical Partners beats PureCycle Technologies on 9 of the 15 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Ecovyst?

Westlake Chemical Partners (NYSE:WLKP) and Ecovyst (NYSE:ECVT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Westlake Chemical Partners has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Ecovyst has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

Ecovyst has a consensus target price of $13.90, suggesting a potential upside of 17.05%. Given Ecovyst's stronger consensus rating and higher possible upside, analysts plainly believe Ecovyst is more favorable than Westlake Chemical Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Westlake Chemical Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Ecovyst
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71

78.3% of Westlake Chemical Partners shares are held by institutional investors. Comparatively, 86.7% of Ecovyst shares are held by institutional investors. 1.1% of Westlake Chemical Partners shares are held by insiders. Comparatively, 1.8% of Ecovyst shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Westlake Chemical Partners and Westlake Chemical Partners both had 1 articles in the media. Westlake Chemical Partners' average media sentiment score of 1.11 beat Ecovyst's score of 0.76 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Westlake Chemical Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ecovyst
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Westlake Chemical Partners has a net margin of 4.69% compared to Ecovyst's net margin of -7.71%. Ecovyst's return on equity of 11.58% beat Westlake Chemical Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Westlake Chemical Partners4.69% 7.15% 4.57%
Ecovyst -7.71%11.58%4.76%

Westlake Chemical Partners has higher revenue and earnings than Ecovyst. Ecovyst is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westlake Chemical Partners$1.17B0.66$48.70M$1.6413.42
Ecovyst$723.50M1.80-$71.13M-$0.55N/A

Summary

Ecovyst beats Westlake Chemical Partners on 10 of the 16 factors compared between the two stocks.

How does Westlake Chemical Partners compare to CVR Partners?

CVR Partners (NYSE:UAN) and Westlake Chemical Partners (NYSE:WLKP) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

43.8% of CVR Partners shares are owned by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are owned by institutional investors. 0.4% of CVR Partners shares are owned by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, CVR Partners and CVR Partners both had 1 articles in the media. Westlake Chemical Partners' average media sentiment score of 1.11 beat CVR Partners' score of 0.53 indicating that Westlake Chemical Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVR Partners
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Westlake Chemical Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CVR Partners pays an annual dividend of $16.00 per share and has a dividend yield of 13.8%. Westlake Chemical Partners pays an annual dividend of $1.89 per share and has a dividend yield of 8.6%. CVR Partners pays out 139.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Westlake Chemical Partners pays out 115.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CVR Partners has raised its dividend for 1 consecutive years. CVR Partners is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CVR Partners has a beta of 0.15, indicating that its share price is 85% less volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVR Partners
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Westlake Chemical Partners
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

CVR Partners has a net margin of 18.89% compared to Westlake Chemical Partners' net margin of 4.69%. CVR Partners' return on equity of 40.08% beat Westlake Chemical Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
CVR Partners18.89% 40.08% 12.08%
Westlake Chemical Partners 4.69%7.15%4.57%

CVR Partners has higher earnings, but lower revenue than Westlake Chemical Partners. CVR Partners is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVR Partners$606.04M2.02$98.66M$11.5010.08
Westlake Chemical Partners$1.17B0.66$48.70M$1.6413.42

Summary

CVR Partners beats Westlake Chemical Partners on 9 of the 16 factors compared between the two stocks.

Get Westlake Chemical Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for WLKP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WLKP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WLKP vs. The Competition

MetricWestlake Chemical PartnersCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$774M$15.87B$4.59B$23.47B
Dividend Yield8.59%2.04%5.03%4.02%
P/E Ratio13.4235.2121.0631.40
Price / Sales0.662.515,857.9020.35
Price / Cash4.3814.5726.6225.09
Price / Book0.974.918.744.77
Net Income$48.70M$376.31M$157.26M$1.07B
7 Day Performance-1.64%-1.49%-1.60%-0.50%
1 Month Performance-5.56%-2.92%-3.55%0.06%
1 Year Performance-1.81%7.69%39.29%17.02%

Westlake Chemical Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WLKP
Westlake Chemical Partners
2.6567 of 5 stars
$22.00
-0.7%
N/A-1.8%$774M$1.17B13.42150
CC
Chemours
4.3753 of 5 stars
$20.53
+1.3%
$24.60
+19.8%
+29.0%$3.09B$5.81BN/A5,700
NGVT
Ingevity
2.1509 of 5 stars
$74.92
+1.2%
$80.00
+6.8%
+52.3%$2.60B$1.17BN/A1,500
PCT
PureCycle Technologies
2.2988 of 5 stars
$8.11
+6.4%
$12.25
+51.0%
-52.1%$1.47B$10.90MN/A120
ECVT
Ecovyst
4.0713 of 5 stars
$12.46
+1.3%
$13.90
+11.6%
+36.8%$1.36B$795.36MN/A880

Related Companies and Tools


This page (NYSE:WLKP) was last updated on 7/12/2026 by MarketBeat.com Staff.
From Our Partners